北站社区100例心房颤动患者抗凝治疗现状

Survey on the treatment of anticoagulation in 100 patients with atrial fibrillation in Beizhan Community

目的 :调查北站社区心房颤动(房颤)患者抗凝治疗现状,为规范社区房颤管理提供参考。方法 :收集2013年1月-2013年12月北站社区门诊持续房颤患者100例,进行问卷调查,内容包括现病史、既往病史、治疗史、凝血酶原监测及凝血酶国际标准化比率知晓情况等,并采用CHADS2评分评价治疗的合理性。结果 :房颤的病因主要为高血压和缺血性心脏病,房颤患者抗凝治疗的比例仅为36%,抗凝治疗的平均时间为6个月;社区尚未开展抗凝治疗患者凝血功能监测。结论 :社区房颤的抗凝治疗尚未展开,需加强和提高社区房颤的规范管理水平。

Objective： To survey the treatment status of anticoagulation in the patients with atrial fibrillation in Beizhan Community to provide a reference for the community standardized management of atrial fibrillation. Methods： One hundred cases with atrial fibrillation in the outpatient department of Zhabei Community Health Service Center from Jan. to Dec. 2013 were collected and investigated with a questionnaire that included the present illness, past history, treatment history, prothrombin monitoring and INR awareness and so on. The score of CHADS2 was used to evaluate the treatment rationality. Results：Hypertension and ischemic heart disease were the major causes of atrial fibrillation, the anticoagulation treatment proportion for atrial fibrillation accounted for only 33%, and the average time of anticoagulation therapy was 6 months. The community did not carry out the monitoring of coagulation function for the patients with anticoagulation therapy. Conclusion： Anticoagulation treatment of atrial fibrillation has not been carried out in the community. It needs to strengthen and enhance the standardized management level of atrial fibrillation in the community.